Skip to main content
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Latest Issue
Issue Archive
Special Issues
Web Exclusives
Special Series
Conference Correspondent
ASH 2023 - CLL
Ovarian Cancer Overview
Multimedia
All Videos
Interview with the Innovators
Quick Quiz
Subscribe
Conference Correspondent
Health-Related Quality of Life in Patients with Metastatic Breast Cancer and Brain Metastases Treated with Tucatinib in Combination with Trastuzumab plus Capecitabine
SABCS 2020 Highlights
Conference Correspondent
Read More ›
NALA Phase 3 Trial Outcomes in Patients Treated with Neratinib or Lapatinib
SABCS 2020 Highlights
Conference Correspondent
Read More ›
HER2CLIMB-02: A Randomized, Double-Blind, Phase 3 Study of Tucatinib with T-DM1 for the Treatment of Unresectable Locally Advanced or Metastatic HER2-Positive Breast Cancer
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Final Overall Survival Analysis from the Randomized Phase 3 ExteNET Trial of Neratinib in Patients with HER2-Positive Early-Stage Breast Cancer
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Hormone Receptor Status Is Not a Factor in the HER2CLIMB Study of Tucatinib Combination Treatment for Patients with HER2-Positive Metastatic Breast Cancer
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Comparison of ARX788 and Lapatinib/Capecitabine in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Efficacy, Safety, and Tolerability of Tucatinib in Combination with Letrozole and Palbociclib in Patients with HR-Positive, HER2-Positive Metastatic Breast Cancer
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Use of Circulating Tumor Cells to Guide Treatment with HER2 Therapy
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Real-World Analysis of Outcomes in Older Women with HER2-Positive Advanced Breast Cancer
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Effect of Brain Metastases in Real-World Treatment Patterns and Healthcare Resource Utilization Among HER2-Positive Metastatic Breast Cancer Patients
SABCS 2020 Highlights
Conference Correspondent
Read More ›
Page 3 of 28
1
2
3
4
5
6